BDR Pharma

BDR Pharma launches Nilotinib to treat PH+ leukemia

Read more

How cloud utilisation can transform the pharma industry

Read more

BDR Pharma launches generic Palbociclib for breast cancer treatment

Read more

BDR Pharma launches maiden generic to treat prostate cancer in India

Read more

By 2023, pharma industry is expected to be worth more than $1 trillion

Read more

Raw material prices affect margins of pharma drugs

Read more

BDR Pharma partners with Varenyam Healthcare to launch Sugmadex in India

Read more

Multiples private equity-led consortium invests Rs 6,850 million in BDR Pharma

Read more

BDR Pharma launches anti-cancer drug Furmecil

Read more

Essential drugs’ price hike: The impact

Read more